Evidence map›Paper›PMID 42192958›Full record

ReviewCancers2026

Non-Cisplatin Concurrent Systemic Therapy with Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Network Meta-Analysis of Randomized Clinical Trials.

Katharina Sophie Schöbel, Anne-Josephin Schoele, Georg Wurschi, Klaus Pietschmann, Maximilian Römer

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katharina Sophie SchöbelDepartment of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany.
Anne-Josephin SchoeleDepartment of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany.
Georg WurschiDepartment of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany.ORCID 0000-0002-8751-9862
Klaus PietschmannDepartment of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany.ORCID 0009-0002-8085-8455
Maximilian RömerDepartment of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany.ORCID 0000-0002-7069-4699

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

carboplatincetuximabchemoradiotherapycisplatin-ineligibleHNSCCimmunoradiotherapysecond-line

Identifiers

PMID42192958
PMCPMC13204043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.